ABSTRACT Pulsatile perfusion has been shown to offer significant haemodynamic advantages over non-pulsatile perfusion in many experimental studies. Clinical acceptance of pulsatile perfusion during cardiac surgical procedures has, however, been hampered by the lack of technologically satisfactory pulsatile pump systems, and by inadequate clinical experience of routine use of pulsatile perfusion. The recent introduction of reliable pulsatile pump systems with low haemolysis characteristics has made possible the clinical validation of the previous experimental studies. We describe the results of a prospective study of mortality, haemodynamic morbidity, and haematological status, in 350 consecutive adult patients submitted to cardiopulmonary bypass procedures in a surgical unit over a 12-month period. One hundred and seventy five patients were perfused with conventional non-pulsatile flow and 175 with pulsatile flow, using a modified roller-pump pulsatile system (Cobe-Stockert). The groups were closely similar in terms of preoperative characteristics, referral category, and pathology requiring surgery. Operative techniques, bypass parameters, and anaesthetic regime were standardised in both groups. The results were as follows. (1) Total mortality was significantly lower in the pulsatile group (4.6%) compared with the non-pulsatile group (10.3%), p = 006. (2) The incidence of deaths attributable to post-perfusion low cardiac output was significantly lower in the pulsatile group (11% compared with 6 3 %, p = 0.02). (3) Requirement for mechanical (intra-aortic balloon) or drug circulatory support was significantly lower in the pulsatile group. (4) The use of pulsatile perfusion was not associated with any increase in haemolysis, blood cell depletion, or postoperative bleeding problems.
Interest in the clinical applicability of pulsatile perfusion has recently been reawakened, both as a result of the development of reliable, commercially available pump systems and in view of recent clinical research defining more clearly the pathophysiological effects of non-pulsatile perfusion.
A prospective clinical study was designed to investigate the clinical applicability of routine pulsatile flow during open-heart procedures, with particular emphasis on the comparative effects of pulsatile and non-pulsatile perfusion on haemodynamic morbidity and mortality statistics. The following specific aims were included in the study. 1 To use pulsatile cardiopulmonary bypass with the Cobe-Stockert system-a modified roller-pump system previously studied by the authors in relation to the metabolic and haemodynamic effects of pulsatile flow, '-4 and assess its clinical applicability in 12-month period. No patients were excluded from the study total, which comprised urgent and emergency cases in addition to elective procedures. Patients were allocated arbitrarily to pulsatile or non-pulsatile perfusion and there were 175 patients in each group. The patients were operated on by one of four consultant cardiac surgeons, each surgeon operating on the same number of patients in the two groups (table 1) .
The patients were assessed in terms of preoperative characteristics (table 2), referral category  (table 3) , and underlying pathology requiring surgery (table 4) . There were no significant differences between the groups in any of these parameters.
All operative procedures were carried out under a standard protocol encompassing anaesthesia, bypass circuitry, oxygenator, prime composition, and immediate postoperative care programme. Anaes- thesia was induced with sodium pentothal and maintained with nitrous oxide, oxygen, and intravenous morphine. The total morphine dosage administered during the operation was <0-2 mg/kg body weight/patient for both groups. Intermittent positive pressure ventilation was maintained throughout operation (except for the bypass period) and for the first 15-20 hours after operation. Though there were more valve patients in the pulsatile group and more coronary patients in the nonpulsatile group, these differences were not significant. Within the valve surgery patients, the pulsatile group had 102 valves replaced (equivalent to 1-32 valves per patient) compared with 70 valves in the non-pulsatile group (1.06 valves per patient). This difference is significant but would bias results in favour of the non-pulsatile group.
Within the coronary disease patients, the pulsatile group had 1-8 coronary artery grafts per patient compared to 1-96 grafts per patient in the nonpulsatile group, but this difference is not significant. There were 20 patients in both pulsatile and nonpulsatile groups who required left ventricular aneurysm resection in addition to coronary artery bypass grafting. There were eight (4.6%) pulsatile patients who required valve replacement plus coronary artery grafting, compared with 10 (5.7%) nonpulsatile patients. (TABLE 6) Only deaths occurring within one month of the day of operation were included in the results. There were eight deaths in the pulsatile group (4.6%) compared with 18 deaths in the non-pulsatile group (10.3%), p = 0-06. Mortality statistics for each group according to referral category showed a mortality for elective cases of 3*25% for the pulsatile group, compared with 8*4% for the non-pulsatile group. The % mortality was also lower in the pulsatile group for urgent and emergency categories, but these differences did not achieve significance.
HAEMODYNAMIC MORBIDITY (TABLE 7) The clinical results were considered in detail in order to document the haemodynamic status of the patients in each group.
Incidence of intraoperative deaths
In the pulsatile group, there was one death during operation, the patient being unable to be weaned off bypass. This represents a mortality of 0.6% of all cases, compared with seven deaths (4%) in the non-pulsatile group, p = 0-07.
Incidence of deaths attributed to low cardiac output occurring within 24 hours of surgery These figures were determined by adding to the intraoperative deaths those patients who survived the operation but died within the first 24 hours as a result of a low cardiac output state. This gave a total of two patients (1.1%) in this category in the pulsatile group, compared with 11 patients (6.3%) in the non-pulsatile group, p = 0.02.
Use of intra-aortic balloon pump (IABP) to wean patients off bypass Mechanical circulatory support with an IABP was used in one patient in the pulsatile group (0.6%) compared with seven patients in the non-pulsatile group (4.0%), p = 0-07. The decision to insert the IABP was taken by the surgeon involved in the par- Topical hypothermia (% of cases) and root flush cardioplegia 5 6
Conversion: traditional to SI units-1 mm Hg = 0-13 kPa. The following four parameters were studiedhaemoglobin concentration, haematocrit, and volume of homologous blood transfused; platelet counts-before and 24 hours after operation; incidence of reopening for excessive bleeding; free haemoglobin-absolute levels and calculation of the rise in plasma-free haemoglobin per unit time during the period of perfusion.
Haemoglobin concentration
In the pulsatile group, the mean preoperative haemoglobin was 14-9 g% (range 9-2-18-2) compared with 14-4 g% (range 9-5-17-4) in the nonpulsatile group. Twenty-four hours after operation the mean haemoglobin levels were 13-0 g% in the pulsatile group and 12-9 g% in the non-pulsatile group.
Packed cell volume in the pulsatile group 24 hours after operation was 37-9% (range [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] [46] and in the non-pulsatile group 34-26% (range 19-45)
Homologous blood was transfused in 136 pulsatile patients and in 142 of the non-pulsatile patients. The mean volume transfused in the pulsatile patients was 2-86 units/case compared with units/case in the non-pulsatile group. None of these differences is significant.
Platelet counts
Preoperative platelet count was 246-7 x 103mm-3 (+8-16 SEM) in the pulsatile group, and 214-23 x 103mm-3 (+6-68 SEM) in the non-pulsatile group. Twenty-four hours after operation, platelet counts were 117-92 x 103mm-3 (+-9-04 SEM) in the pulsatile group and 122-84 x 103mm-3 (+8-68 SEM) in the non-pulsatile group.
Incidence of reopening for excessive postoperative bleeding Ten patients in the pulsatile group required reopen-ing for excessive postoperative bleeding (5 7%), compared with 11 patients in the non-pulsatile group (6.3%). In the 10 pulsatile patients, none had evidence of bleeding arising from or around the site of aortic bypass cannulation.
Plasma-free haemoglobin levels (table 8) Plasma-free haemoglobin levels were determined by the photometric method of Cripps5 five minutes before the onset of perfusion (pre-perfusion sample) and five minutes before the end of perfusion (endperfusion sample). In addition to these absolute values, the rise in free haemoglobin during perfusion was calculated and expressed in relation to the duration of perfusion to give the haemolysis index A Plasma free Hb during perfusion (mg/100 ml) Total perfusion time (min) The pre-perfusion level was <5 mg/100 ml in both groups. In the pulsatile group, the mean level at the end of perfusion was 43-62 mg/100 ml (range 18-64), compared to 46-48 mg/100 ml (range 22-101) in the non-pulsatile group. It should be noted, however, that in none of the pulsatile patients was the end-perfusion free haemoglobin >70 mg/ 100 ml, whereas levels up to 101 mg/100 ml were found in the non-pulsatile group. The rise in free haemoglobin concentration during perfusion was not significantly different between the groups, nor was the difference in the haemolysis index.
Disussion
There is general agreement among previous investigators that non-pulsatile perfusion is associated with an increase in peripheral vascular resistance (PVR) during the period of perfusion and that pulsatile perfusion is accompanied by significantly lower PVR levels.6-'0 The increased clinical awareness of excessive vasoconstriction after cardiopulmonary bypass procedures' '-" has been reflected in studies concerned with the pathophysiology and treatment of the elevation in PVR. It is now widely recognised that elevated PVR is a potentially hazardous situation in the early post-bypass period, In considering the haemodynamic effects of pulsatile perfusion it is necessary to distinguish between (1) the primary effect of reducing elevated levels of PVR and thus promoting better tissue perfusion, reflected in previous studies demonstrating superior peripheral organ function (eg brain, kidney, pancreas) with pulsatile perfusion, and (2) the secondary effect of improving subsequent left ventricular performance by exposing the left ventricle at the end of perfusion to a significantly lower level of PVR compared with that produced by non-pulsatile perfusion.
It is important to realise that this secondary effect relates to the concept of afterload as an important, even primary, determinant of left ventricular performance'5 and is separate from any additional direct effect of pulsatile perfusion on the coronary circulation. The results of the present study suggest a significant haemodynamic superiority in the pulsatile group, in terms of both mortality and morbidity.
The essential similarity between the pulsatile and non-pulsatile groups in terms of preoperative characteristics, referral category, and operative protocol accentuates the significantly lower mortality figures in the pulsatile group. Indeed, with a greater number of valve replacement procedures in the pulsatile group one might have anticipated a higher mortality in this group. Detailed consideration of the haemodynamic parameters in both groups gives a clear indication of a fundamental difference in haemodynamic status in the pulsatile group. In particular, there was a significantly lower incidence of low-output-related intraoperative and immediate postoperative deaths when compared with the nonpulsatile group. This clinical finding is in agreement with the results of previous experimental studies, indicating a significant improvement in postperfusion cardiac performance after pulsatile perfusion. [23] [24] [25] The finding of a reduced requirement for circulatory support, with intra-aortic balloon or inotropic drugs, is in keeping with the overall haemodynamic superiority in the pulsatile group. Bregman26 has reported a similar reduction in the need for postperfusion balloon pumping, and a reduced incidence of perioperative myocardial infarction, in patients perfused with pulsatile flow. Similar findings have been reported by Pappas.27 It is likely that the haemodynamic superiority of pulsatile perfusion will be most apparent in patients whose left ventricular function is already severely compromised before operation. In such patients, with severe valvular disease, or ischaemic left ventricular dysfunction, the prevention of excessive elevation in PVR during perfusion may consequently prevent the development of a low-output state in the immediate post-perfusion period.
There is no doubt that certain of the pulsatile systems used in early experimental studies were associated with a high index of haemolysis.28 29 The complexity of some early systems and the non-linearity of flow patterns may have caused significant blood cell trauma. More recently, however, haemolysis studies have suggested that pulsatile perfusion does not increase haemolysis to any significant extent,30 though Zumbro's group3' have reported increased haemolysis using the balloon inflation/deflation PAD system (Datascope).
Extensive haematological studies in the present series and in previous reports have shown that in our experience pulsatile perfusion using the CobeStockert system has not been associated with any significant increase in blood cell trauma or depletion. 32 The haemolysis figures in the present series have shown that no pulsatile patient had an endperfusion free haemoglobin concentration of >70 mg/100 ml. These acceptably low figures have recently been confirmed by Soyer's group in Rouen, also using the Cobe-Stockert system (Soyer, personal communication 1979).
There is an obvious need to determine the haemolysis characteristics of all clinically applicable pulsatile pump systems (particularly those of the intermittent inflation/deflation balloon type) in view of Zumbro's It is likely, however, that there are certain features of the pulsatile wave-form which make it "recognisable" to the body as pulsatile perfusion. Where these features are seriously deficient, the disorders associated with non-pulsatile perfusion will result. We share the opinion, expressed by Wright34 and by Rainer, 35 that the rate of rise of the pressure and/or flow profile in the arterial circulation is likely to be at least a major feature of phsyiological significance. Where the upstroke of the pressure curve is "slurred," the physiological effects of pulsatility may be lost.
Condusions
The following conclusions may be drawn from the results of the present study concerning the use of pulsatile perfusion during open-heart surgical procedures. 1 The use of pulsatile perfusion with the modified roller-pump system (Cobe-Stockert) has not been associated with any increase in haemolysis, blood cell depletion, or postoperative bleeding problems. 2 Comparison of mortality in a parallel series of pulsatile and non-pulsatile perfusions has shown a significantly lower mortality in the pulsatile group. 3 The significantly lower total mortality was associated with a significantly lower incidence of deaths attributable to low cardiac output during operation or in the post-perfusion period. 4 Requirement for mechanical or drug circulatory support in the post-perfusion period was significantly lower in the pulsatile group. These results suggest that the routine use of pulsatile perfusion during cardiopulmonary bypass offers significant haemodynamic advantages over conventional non-pulsatile perfusion. Those who, like us, would advocate the adoption of pulsatile perfusion in cardiac surgical practice believe it to be a significant contribution to the overall safety of open-heart surgical procedures.
